Tag Archive
Arrowhead Receives Additional 180-Day Grace Period to Comply with the NASDAQ $1.00 Minimum Bid Requirement (Business Wire via Yahoo! Finance)
PASADENA, Calif.—-Arrowhead Research Corporation today announced that, on March 16, 2010, it received a notification from the NASDAQ Stock Market indicating that the Company will have an additional 180-day grace period, until September 13, 2010, to regain compliance with NASDAQ’s $1.00 minimum bid requirement. (read the story…) Related items Arrowhead seeks to regain Nasdaq compliance (Whittier Daily... »
News Item (ChemPoint)
ALBUQUERQUE, New Mexico, March 17, 2010 — Iosil Energy Corporation (”Iosil”), an innovator in the production of high-purity solar grade polysilicon for the photovoltaic industry, announced today that it has secured $13.5 million in equity financing in an oversubscribed round. (read here…) Related items Iosil Energy Corporation Secures First Close on $13.5M in Equity Financing to Build... »
Rusnano to become joint-stock company in 2010 (RosBusinessConsulting)
RBC, 16.03.2010, Moscow 17:08:36. The Russian Corporation of Nanotechnologies (Rusnano) will become a joint-stock company in 2010, President of the state corporation Anatoly Chubais told journalists today, the NTV channel reported. (read the story…) Related items Rusnano, Gazprombank strike cooperation deal (RosBusinessConsulting) Rusnano to assist nanotechnology centers (RosBusinessConsulting) Russian Silicon Valley may be formed soon (RosBusinessConsulting) Russian enterprises urged to... »
CombiMatrix Corporation Retires All Remaining Convertible Debt (GlobeNewswire via Yahoo! Finance)
MUKILTEO, Wash. — CombiMatrix Corporation announced today that it has fully repaid the secured convertible debenture held by YA Global Investments, L.P., which had an original principal amount of $10.0 million. (read the story…) Related items Combimatrix Molecular Diagnostics Strengthens Management Team (GlobeNewswire via Yahoo! Finance) CombiMatrix Corporation Engages Robert W. Baird as Financial and Strategic Advisor (GlobeNewswire... »
Celsion’s Technology Is The Focus Of 6.4 Million EUR ‘HIFU-CHEM’ Program To Study ThermoDox(R) And MRI-guided HIFU (Medical News Today)
Celsion Corporation (Nasdaq: CLSN) announced that a proposal entitled “Application of MRI-guided HIFU to Improve Cancer Chemotherapy with Temperature-Sensitive Targeted Nanomedicines (HIFU-CHEM)” submitted to the Center for Translational Molecular Medicine (CTMM) has been approved for funding. This project, lead by University Medical Center Utrecht in the Netherlands will bring together several … (read the story…) Related... »
